|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
Stronger technical forecast for Celldex Therapeutics stock price after Monday trading
(Updated on Nov 17, 2025)
The Celldex Therapeutics stock price gained 1.76% on the last trading day (Monday, 17th Nov 2025), rising from $25.55 to $26.00. During the last trading day the stock fluctuated 4.11% from a day low at $25.46 to a day high of $26.50. The price has fallen in 7 of the last 10 days but is still up by 5.05% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 183 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $29.14 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.69% during the next 3 months and, with a 90% probability hold a price between $25.58 and $32.17 at the end of this 3-month period.
CLDX Signals & Forecast
The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $24.21 and $25.87. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, November 10, 2025, and so far it has risen 14.69%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Celldex Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $24.61 and $22.02. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Celldex Therapeutics finds support just below today's level at $24.61. If this is broken, then the next support from accumulated volume will be at $22.02 and $20.89.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.05 between high and low, or 4.11%. For the last week, the stock has had daily average volatility of 7.02%.
Our recommended stop-loss: $24.93 (-4.10%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 5 days ago.)
Trading Expectations (CLDX) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect Celldex Therapeutics to open at $25.99, and during the day (based on 14 day Average True Range), to move between $25.37 and $26.63, which gives a possible trading interval of +/-$1.26 (+/-4.97%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 4.97% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $26.72 (2.77%) than the support at $24.61 (5.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Celldex Therapeutics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Celldex Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
2.087
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $25.99 ( 0.0577%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CLDX Performance
Trading levels for CLDX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 27.03 | 3.96% |
| R2 | 26.63 | 2.43% |
| R1 | 26.38 | 1.48% |
| Price | 26.00 | |
| S1 | 25.59 | -1.59% |
| S2 | 25.34 | -2.54% |
| S3 | 24.94 | -4.08% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 26.77 | 2.96% |
| R2 | 26.73 | 2.81% |
| R1 | 26.72 | 2.77% |
| Price | 26.00 | |
| S1 | 24.61 | -5.35% |
| S2 | 22.02 | -15.31% |
| S3 | 20.89 | -19.65% |
FAQ
Click here for our free guide on how to buy Celldex Therapeutics Stock.
Buy CLDX